Search Results 931-940 of 18296 for prostate cancer
... prostate cancer progression. The test was evaluated in a blinded study of 1,010 Mayo Clinic patients at high risk for the spread of prostate cancer. "The ...
Flutamide is used together with a luteinizing hormone-releasing hormone (LHRH) agonist to treat metastatic (cancer that has spread) prostate cancer in men.
Researchers are looking for new ways to treat metastatic castration-resistant prostate cancer (mCRPC). Researchers have designed a study medicine called ...
The purpose of this study is to determine the safety of the NanoKnife treatment in prostate cancer tissue when used in a low and intermediate risk patient ...
A Study to Collect Surgical Tumor Samples for Prostate Cancer-derived Tissue Graft. Rochester, Minn. The purposes of this study are to collect prostate ...
... prostate cancer. The objectives are to describe the practice patterns of therapeutic agents for treatment of advanced prostate cancer internationally; to ...
Treatments such as chemotherapy, hormone therapy and immunotherapy have had limited success against advanced prostate cancer due to the tumor's ability to ...
... prostate cancer. Prostate Cancer Prostatic Dis. 2022 Sep; 25 (3):479-483 Epub 2021 July 22. View PubMed; Nafissi NN, Kosiorek HE, Butterfield RJ, Moore C, Ho ...
Expertise in management of solid tumor malignancy such as prostate cancer, bladder cancer, kidney cancer, melanoma, etc. · Complex coordination of care for ...
... prostatic hyperplasia, Prostate cancer, Bladder cancer, Kidney cancer, Ureteral cancer. Show more areas of focus for Paras H. Shah, M.D. ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.